000 03708nam a22005415i 4500
001 978-3-540-37861-7
003 DE-He213
005 20161121230645.0
007 cr nn 008mamaa
008 100301s2006 gw | s |||| 0|eng d
020 _a9783540378617
_9978-3-540-37861-7
024 7 _a10.1007/978-3-540-37861-7
_2doi
050 4 _aRG1-991
072 7 _aMJT
_2bicssc
072 7 _aMED033000
_2bisacsh
082 0 4 _a618.1
_223
245 1 0 _aBiology und Epidemiology of Hormone Replacement Therapy
_h[electronic resource] :
_bDiscussions on Post-Menopausal Health /
_cedited by M. A. Lewis, M. Dietel, P. C. Scriba, W. K. Raff.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2006.
300 _aXV, 179 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aErnst Schering Research Foundation Workshop Supplement 13,
_x0947-6075 ;
_v13
505 0 _aThe Presentations -- to the Presentations -- Women Between Biology and Civilization -- Issues with the Term “Responsibility” -- Epidemiology of Selected Diseases in Women -- Pathogenesis of Histological Types of Endometrial Cancer -- Pathology of the Colon and Ovary -- The Progenitor Cell Concept of Proliferative Breast Disease -- Indication for HRT: Climacteric Complaints and Osteoporosis -- HRT and Cardiovascular Disease in Women -- The Million Women Study -- Paradigm Shift in Causal Thinking in Epidemiology -- Perception and Communication of Risk -- Some Thoughts After the Kloster Andechs Workshop, August 2003 -- The General Discussion -- Menopause and the HRT Risk — Benefit Equation: Status and Outlook -- Conclusions of the Kloster Andechs Workshop -- Workshop Consensus: The State of the Evidence.
520 _aDie Vor- und Nachteile der Hormonersatztherapie (HRT) werden von einer Expertengruppe hinsichtlich der epidemiologischen Beweislage diskutiert. Den Diskussionsschwerpunkt bildet jedoch die Problematik des Brustkrebsrisikos. Unter anderem wird gezeigt, dass die aus epidemiologischen Studien abgeleiteten Ergebnisse sich nicht mit den Wachstumseigenschaften dieser Tumoren decken, so dass weiterführende Bevölkerungsuntersuchungen unter Einbeziehung pathobiologischen Sachverstands notwendig erscheinen. The benefits and risks of hormone replacement therapy (HRT) are discussed by a group of experts with a view towards the evidence provided by recent epidemiological studies. Although all aspects of HRT indications and contra-indications are reviewed, the particular emphasis of this discussion is on breast cancer. Among other things, it is shown that the evidence on breast cancer provided in epidemiological studies does not match the growth characteristics of the tumours, and that further population research incorporating pathobiological assessments is required.
650 0 _aMedicine.
650 0 _aGynecology.
650 0 _aOncology.
650 0 _aPathology.
650 0 _aEpidemiology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aGynecology.
650 2 4 _aEpidemiology.
650 2 4 _aOncology.
650 2 4 _aPathology.
700 1 _aLewis, M. A.
_eeditor.
700 1 _aDietel, M.
_eeditor.
700 1 _aScriba, P. C.
_eeditor.
700 1 _aRaff, W. K.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783540323419
830 0 _aErnst Schering Research Foundation Workshop Supplement 13,
_x0947-6075 ;
_v13
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-540-37861-7
912 _aZDB-2-SME
950 _aMedicine (Springer-11650)
999 _c502005
_d502005